Skip to main content

LinkedIn
Instagram
Facebook
YouTube
Email

People
Events
News

Search site:

National Cancer Institute

Frederick National Laboratory

Menu

Mega Menu

Research & Technology
- Science Areas
  - AIDS and Cancer Virus Program
  - Basic Science Program
  - Bioinformatics and Computational Science
  - Cancer Research Technology Program
  - Laboratory Animal Sciences Program
  - Vaccine, Immunity, and Cancer Directorate
  HIV/SIV research
  Researchers identify lower GI tract tissues as source of initial rebound of HIV-like virus after stopping ART
  A new study used an innovative method to track anatomic origin of rebound of HIV-like virus.
- Clinical Trial Support
  - Applied and Developmental Research Directorate
  - Biopharmaceutical Development Program
  - Clinical Monitoring Research Program
  - Clinical Research Directorate
  - Vaccine Clinical Materials Program
  Analysis of paired blood biopsies, tumor tissue as biomarkers for cancer to be presented at ASCO
  FNL scientists will present a recent study comparing mutations found in paired tuors and ctDNA at the 2026 American Society for Clinical Oncology Annual Meeting.
- Publications
NIH partnership establishes new Gene Therapy Immunology and Standards Laboratory
A new initiative aims to standardize gene therapy research, speeding the path to clinical trials and new treatments.
Innovation & Initiatives
- Initiatives
  - RAS Initiative
  - Scientific Standards Hub
  Save the date Oct 7-9, 2026
  
  6th RAS Initiative Symposium
  Join us for the 2026 RAS Initiative Symposium.
- Innovation
  - Center for Innovation and Strategic Partnerships
  - Patents
  Importance of innovation Within FNL, innovation plays a pivotal role in delivering new and enhanced technologies that empower us to tackle essential scientific inquiries, enhance our services, and ultimately contribute to the wellbeing of patients.
  Vladimir Popov, Ph.D., MBA
- Scientific Series
  Sep 9, 2026
  
  2026 Technology Showcase
  Free, in-person event with networking and one-on-one partnering opportunities.
American Association for Cancer Research Annual Meeting
Preclinical data on potential treatment for RAS-driven cancers to be presented at AACR26
Studies on BBO-10203 and BBO-11818 will be presented in San Diego.
Investigator Resources
Training
FNL Global Clinical Research Educational Modules
Learn about challenges in clinical research during emergency infectious disease outbreaks and strategies to overcome them.
Work With Us
Vendor Webinar Sep 24, 2026

Q3 How to Do Business with Leidos Biomedical Research
This session will provide a roadmap for navigating the procurement process.
Careers
Brilliant teamwork The team here is made up of brilliant scientists. Coming from a diverse research background myself, it’s inspiring to be in a room where everyone contributes something unique. I feel truly privileged to be part of it.
Samarth Mathur, Ph.D.
About FNL
Did you know?

In the 10-year period 2012-2022, the Vaccine Clinical Materials Program completed 300+ shipments supporting approximately 100 clinical trials across 45 products.

Publications

Body

Below you'll find a list of all our scientific publications.

Only authors from the Frederick National Laboratory for Cancer Research are displayed.

Search

Search by title, keyword, or author. Use the filters to narrow results by specific programs and laboratories.

Search

[Apply]

Filters

Publication Date

Min

Max

Directorate / Lab / Affiliation

AIDS Monitoring Laboratory

AIDS and Cancer Virus Program

Advanced Biomedical Computational Science

Advanced Cryo-Electron Microscopy Technology Group

Animal Diagnostics Laboratory

Animal Research Technical Support

Antibody Characterization Laboratory

Applied and Developmental Research Directorate

Basic Science Program

Bioinformatics and Computational Science

Biological Products Core

Biopharmaceutical Development Program

Biophysics and Computational Biology Section

Bioprocessing Laboratory

Biospecimen Research Group

Blood Processing Core

Cancer Genomics Research Laboratory

Cancer Imaging Informatics Laboratory

Cancer Immunoprevention Laboratory

Cancer Research Technology Program

Cellular Immunity Core

Center for Technical Operations Support

Clinical Monitoring Research Program

Clinical Support Laboratory

Contracts and Acquisitions

Drug Discovery and Development Program

Epigenetics Section

Flow Cytometry Support Laboratory

Genome Modification Core

Gnotobiotics Facility

HIV Molecular Monitoring Core

HLA Immunogenetics Section

HPV Serology Laboratory

Imaging Mass Cytometry Laboratory

Immunological Monitoring Laboratory

In Vitro Evaluation and Molecular Pharmacology Laboratories

In Vivo Evaluation Program

Investigative Toxicology Laboratory

Laboratory Animal Medicine

Laboratory Animal Sciences Program

Laboratory of Human Retrovirology and Immunoinformatics

Laboratory of Molecular Cell Biology

Molecular Histopathology Laboratory

Molecular Immunology Section

Molecular Pharmacology Program

Mouse Modeling and Cryopreservation

Nanotechnology Characterization Laboratory

National Cryo-Electron Microscopy Facility

Natural Products Support Group

Neutrophil Monitoring Laboratory

Nonhuman Primate Research Support Core

Pharmacokinetics and Drug Analysis Group

Protein Expression Laboratory

Quantitative Molecular Diagnostics Core

Radiochemistry Program

Radiochemistry Support Group

Retroviral Evolution Section

Retroviral Pathogenesis Section

Retrovirus-Cell Interaction Section

Small Animal Imaging Program

Tissue Analysis and Retroviral Protein Chemistry Core

Vaccine Clinical Materials Program

Vaccine, Immunity, and Cancer Directorate

Viral Evolution Core

Viral Oncology Section

Viral Persistence Section

Virus Isolation and Serology Laboratory

May1

2026

Cross-ancestry proteome-wide Mendelian randomization prioritizes 12 plasma protein candidates for breast cancer risk

medrxiv

PMID 42145630

Godbole D, and 7 more

Clinical Research Directorate › Cancer Genomics Research Laboratory

May1

2026

Derivation and characterization of ubiquitin-specific protease 18 inhibitors

JCI Insight

PMID 42154529

Ogunlade BO, Okpechi SC, Tyutyunyk-Massey L, Chen Z, Liu X, Ivanic J, Luke B, Alfaro Y, Liu X, Dmitrovsky E, and 6 more

Bioinformatics and Computational Science › Advanced Biomedical Computational Science, Cancer Research Technology Program › Molecular Pharmacology Program

May1

2026

Distinct phases of immune system programming during ART-suppressed immunodeficiency virus infection

bioRxiv (Preprint)

PMID 42094348

Keele BF, Lifson JD, and 18 more

AIDS and Cancer Virus Program › Retroviral Evolution Section, Retroviral Pathogenesis Section

May1

2026

Distributed Clonal Deletion Prevents Autoimmune Disease Progression

biorXiv

PMID 42182255

Karim B, Bassel L, and 16 more

Laboratory Animal Sciences Program › Molecular Histopathology Laboratory

May1

2026

Genetic Determinants of Spontaneous Hepatitis B Surface Antigen Seroclearance and Its Associated Viral Markers

Aliment Pharmacol Ther

PMID 42108971

Wang K, and 11 more

Clinical Research Directorate › Cancer Genomics Research Laboratory

May1

2026

HDAC inhibition unlocks tumor plasticity and enhances immunotherapy response in Myc-driven small cell lung cancer

Mol Cancer Ther

PMID 42068133

Weaver Ohler Z, El Meskini R, Atkinson D, Day A, Bassel L, and 11 more

Laboratory Animal Sciences Program › Animal Research Technical Support, Molecular Histopathology Laboratory

May1

2026

High yield production of C-terminally processed KRAS4a, HRAS, and NRAS for biophysical study

Protein Expr Purif

PMID 42142681

Perkins S, Krahnke S, Larsen EK, Drew M, Frank PH, Hong M, Rabara D, Wall VE, Grose C, Gillette W, Esposito D, Stephen AG, Messing SA

Cancer Research Technology Program

May1

2026

Integrating AI in Medicinal Chemistry for Accelerated Drug Discovery: A Comprehensive SAR (CSAR) Optimization Strategy and Discovery of Potent ALDH3A1 Inhibitors

J Med Chem

PMID 42216908

Denson JP, Esposito D, and 14 more

Cancer Research Technology Program

May1

2026

Integrating In Situ Immune Expression Landscape with Gene Expression-Based Subtyping to Characterize Breast Cancer Heterogeneity

Cancer Epidemiol Biomarkers Prev

PMID 42171349

Lawrence S, Mutreja K, Jones K, Vogt A, Brown M, Hicks BD, Wang D, and 15 more

Clinical Research Directorate › Cancer Genomics Research Laboratory

May1

2026

MVA-BN Mpox vaccine safety in adults results from an observational study in the Democratic Republic of the Congo

NPJ Vaccines

PMID 42209512

Bonnett T, Yox E, Tshiani Mbaya O, and 18 more

Clinical Monitoring Research Program

Pagination

First page
Previous page
Page 1
Page 2
Page 3
Current page 4
Page 5
Page 6
Page 7
Page 8
Page 9
…
Next page
Last page

Frederick National Laboratory for Cancer Research is operated by Leidos Biomedical Research, Inc. for the National Cancer Institute.

LinkedIn
Instagram
Facebook
YouTube
Email

Quick Links

Contact Us
Accessibility
Conflict of Interest
Privacy Policy
HHS Vulnerability Disclosure

National Cancer Institute

U.S. Department of Health and Human Services
National Institutes of Health
National Cancer Institute
USA.gov

Research & Technology
Innovation & Initiatives
Investigator Resources
- All Resources
- Data & Repositories
- National Scientific User Facilities
  - Nanotechnology Characterization Laboratory
  - National Cryo-Electron Microscopy Facility
- Training & Education
- Technical Services
- Universal Standards & Reference Materials
Work With Us
Careers
About